These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 213017)

  • 21. Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion.
    Shand GH; Anwar H; Brown MR
    J Antimicrob Chemother; 1988 Dec; 22(6):811-21. PubMed ID: 2854118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to polymyxin B in penicillin G-induced Proteus mirabilis L forms and spheroplasts.
    Teuber M
    J Bacteriol; 1969 May; 98(2):347-50. PubMed ID: 4306537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.
    Hussein M; Han ML; Zhu Y; Zhou Q; Lin YW; Hancock REW; Hoyer D; Creek DJ; Li J; Velkov T
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium.
    Vaara M; Vaara T
    Antimicrob Agents Chemother; 1981 Apr; 19(4):578-83. PubMed ID: 6264852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electron microscopic observations of polysaccharide components in polymyxin B treated outer membranes from Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1979 Jan; 32(1):66-72. PubMed ID: 83989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudomonas cepacia resistance to antibacterials.
    Richards RM; Richards JM
    J Pharm Sci; 1979 Nov; 68(11):1436-8. PubMed ID: 512895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 31. Conversion of phospholipids to free fatty acids in response to acquisition of polymyxin resistance in Pseudomonas aeruginosa.
    Champlin FR; Gilleland HE; Conrad RS
    Antimicrob Agents Chemother; 1983 Jul; 24(1):5-9. PubMed ID: 6312874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of calcium or manganese on the resistance to EDTA, polymyxin B or cold shock, and the composition of Pseudomonas aeruginosa grown in glucose- or magnesium-depleted batch cultures.
    Kenward MA; Brown MR; Fryer JJ
    J Appl Bacteriol; 1979 Dec; 47(3):489-503. PubMed ID: 232101
    [No Abstract]   [Full Text] [Related]  

  • 33. Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance.
    Conrad RS; Galanos C
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1724-8. PubMed ID: 2556077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of nutrient depletion on the drug resistance of a polymyxin-sensitive Proteus mirabilis [proceedings].
    Dujaili AA; Klemperer RM; Brown MR
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():8P. PubMed ID: 22714
    [No Abstract]   [Full Text] [Related]  

  • 35. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    Fierer J; Finley F
    J Infect Dis; 1979 Oct; 140(4):581-9. PubMed ID: 229175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide.
    Duwe AK; Rupar CA; Horsman GB; Vas SI
    Antimicrob Agents Chemother; 1986 Aug; 30(2):340-1. PubMed ID: 3021053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of polymyxin B to restore sensitivity to quinolones for Pseudomonas aeruginosa.
    Walterspiel JN
    South Med J; 1989 May; 82(5):672. PubMed ID: 2541510
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
    Pogue JM; Jones RN; Bradley JS; Andes DR; Bhavnani SM; Drusano GL; Dudley MN; Flamm RK; Rodvold KA; Ambrose PG
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of polymyxin B on liposomes prepared from cholera & El Tor Vibrios.
    Sur P; Maiti M
    Indian J Exp Biol; 1980 Feb; 18(2):112-4. PubMed ID: 6249729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.